Chiron Real Estate Earnings Call Transcripts
Fiscal Year 2025
-
Expanded into senior housing and active adult segments to capture demographic-driven growth, while maintaining stable medical office performance. Improved leverage, initiated asset recycling, and set 2026 Core FFO guidance at $4.30–$4.45 per share.
-
Third-quarter results showed 2.7% same-store NOI growth, 95% occupancy, and 4% year-over-year AFFO per share growth. The company extended debt maturities, maintained disciplined capital allocation, and expects occupancy to reach 96% by year-end.
-
Leadership transition completed with a focus on growth, asset recycling, and balance sheet strength. Occupancy is expected to exceed 95% by year-end, with recent acquisitions yielding 8.5% and a dividend reduction freeing $17 million annually for reinvestment.
-
Q1 2025 saw stable portfolio performance with 95.6% occupancy and net income rising to $2.1 million. AFFO guidance for 2025 is reaffirmed at $0.89–$0.93 per share/unit, with CEO succession on track and capital recycling ongoing. Leverage remains elevated but within a manageable range.
Fiscal Year 2024
-
Q4 2024 saw 96.4% occupancy, $1.4M net income, and AFFO per share of $0.22, with strong acquisition and disposition activity. 2025 AFFO guidance is $0.89–$0.93 per share, and a CEO transition is underway, while the portfolio remains resilient despite tenant bankruptcy risk.
-
Q3 2024 saw high portfolio occupancy and continued disciplined growth, with net income and FFO per share down year-over-year due to tenant issues. Major acquisitions and asset recycling supported a strong balance sheet, while a new long-term lease with Christus Health replaced Steward at Beaumont.
-
Portfolio occupancy remains strong at 96.2% with steady lease terms and high rent coverage. Q2 saw a net loss due to a property sale, but FFO and AFFO only declined slightly. Acquisition activity is robust, with a $120 million pipeline at attractive cap rates, and asset recycling continues to fund growth.